Management of Gluteal Hematoma in Post-PCI Patients

Immediate Assessment and Risk Stratification

In patients with recent cardiac issues and PCI on aspirin and clopidogrel who develop a gluteal hematoma, the European Society of Cardiology recommends continuing aspirin monotherapy while temporarily holding clopidogrel, performing urgent imaging to assess hematoma size and rule out active bleeding, and planning for early resumption of dual antiplatelet therapy within 3-5 days once hemostasis is confirmed 1, 2
The American Heart Association suggests that complete cessation of dual antiplatelet therapy is an independent predictor of stent thrombosis and mortality, particularly in the early post-PCI period, and advises against discontinuing both antiplatelet agents simultaneously 1, 2, 3

The European Society of Cardiology recommends continuing aspirin 75-100 mg daily even during active bleeding management, as maintaining at least one antiplatelet agent is critical for preventing stent thrombosis 5, 3
The American College of Cardiology suggests temporarily discontinuing clopidogrel only if the hematoma is expanding or causing hemodynamic instability 1, 2

The American Heart Association recommends resuming clopidogrel within 3-5 days once imaging confirms hematoma stability and hemoglobin stabilizes 6, 1
For patients less than 1 month post-PCI, the European Society of Cardiology advises aiming for resumption within 48-72 hours given extremely high stent thrombosis risk 4, 2

The American College of Cardiology suggests avoiding excessive red blood cell transfusion – transfuse only if hemoglobin is low or hemodynamic instability persists, as transfusion releases ADP and paradoxically increases platelet reactivity and thrombotic risk 3
The European Society of Cardiology recommends applying local compression if hematoma is superficial and accessible 3

The American Heart Association advises initiating proton pump inhibitor (PPI) therapy intravenously if not already prescribed – PPIs significantly reduce gastrointestinal bleeding risk with dual antiplatelet therapy and should be continued indefinitely 4, 5, 3
The European Society of Cardiology suggests avoiding NSAIDs, anticoagulants, and other medications that increase bleeding risk during the acute phase 6, 4

The European Society of Cardiology notes that patients with recent cardiac arrest and PCI have extremely high thrombotic risk due to underlying acute coronary syndrome, endothelial injury from resuscitation, and potential for cardiogenic shock 1, 2
The American College of Cardiology states that the mortality risk from stent thrombosis far exceeds the mortality risk from gluteal hematoma in most cases 1, 2, 3